STONKWHISPER
← Back to Intel
Insider ActivityRXRX

Taylor Ben R, Chief Financial Officer at RECURSION PHARMACEUTICALS, INC., traded $149K of RXRX

Updated Jun 11, 2026
Taylor Ben R Chief Financial Officer
RECURSION PHARMACEUTICALS, INC. · $RXRX
$149K Total Value
48,028 Shares Traded
$3.11 Price / Share
1,132,290 Shares Owned After
2026-04-08 Filing Date

Transaction Details

InsiderTaylor Ben R
TitleChief Financial Officer
CompanyRECURSION PHARMACEUTICALS, INC.
TickerRXRX
Transaction TypeTax
Transaction Date2026-04-06
Shares Traded48,028
Price Per Share$3.11
Total Value$149K
Filed Date2026-04-08
Accession Number0001712276-26-000003

Ownership Context

Shares Owned After Transaction1,132,290
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001712276-26-000003

Other Insider Trades — RXRX

Other Trades by Taylor Ben R

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for RXRX — RECURSION PHARMACEUTICALS, INC. →

Whisper Score — RXRX

37.66
Murmurs
Current Whisper Score

See full analysis for RXRX →

Track RXRX insider activity in real time on The Wire →

Get alerts when Taylor Ben R files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 11, 2026 at 07:21 UTC

Want real-time data? Access The Wire for live sentiment tracking.